Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y)

Santema, B. T.; Chan, M. M. Y.; Tromp, J.; Dokter, M.; Van Der Wal, H. H.; Emmens, J. E.; Takens, J.; Samani, N. J.; L. L., Ng; Lang, C. C.; Van Der Meer, P.; Ter Maaten, J. M.; Damman, K.; Dickstein, K.; Cleland, J. G.; Zannad, F.; Anker, S. D.; Metra, M.; Van Der Harst, P.; De Boer, R. A.; Van Veldhuisen, D. J.; Rienstra, M.; Lam, C. S. P.; Voors, A. A.

doi:10.1007/s00392-020-01762-2

The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y) / Santema, B. T.; Chan, M. M. Y.; Tromp, J.; Dokter, M.; Van Der Wal, H. H.; Emmens, J. E.; Takens, J.; Samani, N. J.; Ng, L. L.; Lang, C. C.; Van Der Meer, P.; Ter Maaten, J. M.; Damman, K.; Dickstein, K.; Cleland, J. G.; Zannad, F.; Anker, S. D.; Metra, M.; Van Der Harst, P.; De Boer, R. A.; Van Veldhuisen, D. J.; Rienstra, M.; Lam, C. S. P.; Voors, A. A.. - In: CLINICAL RESEARCH IN CARDIOLOGY. - ISSN 1861-0684. - (2021). [10.1007/s00392-020-01762-2]